Кафедра внутрішньої медицини № 2

Постійне посилання на фонд

https://repository.pdmu.edu.ua/handle/123456789/12

Переглянути

Перегляд Кафедра внутрішньої медицини № 2 за Автор "Burya, L. V."

Зараз показуємо 1 - 2 з 2
  • Ескіз недоступний
    Документ
    Chronic obstructive pulmonary disease and comorbidities: management of somatoform disorders
    (Aluna Publishing, Польща, 2021) Burya, L. V.; Kapustianska, A. A.; Moiseieva, N. V.; Vakhnenko, A. V.; Rumiantseva, M. O.; Zviagolska, I. M.; Буря, Лілія Володимирівна; Капустянська, Анна Анатоліївна; Моісєєва, Наталія Віталіївна; Вахненко, Андрій Вікторович; Рум'янцева, Марія Олександрівна; Звягольська, Ірина Миколаївна
    The aim: To perform a comprehensive evaluation of the effect of paroxetine on the degree of somatoform disorders in exacerbation of severe COPD in women. Materials and methods: The study involved 53 female patients with severe COPD (Group D), confirmed by instrumental methods of study. At hospitalization, patients were divided into 2 groups. Patients of Group 1 (n = 21; aged 52.5 ± 0.8 years old) underwent basic exacerbation therapy. Patients of Group 2 (n = 22; aged 57.9 ± 0.4 years old) underwent basic exacerbation therapy supplemented with paroxetine for 14 days, 1 tablet (0.20 g) once a day. Results: The basic therapy for treatment of COPD exacerbations, supplemented with paroxetine, led to a positive clinical effect, confirmed by increase in skeletal and respiratory muscular system, increased parameters of pulmonary ventilation, increased tolerance to physical load, increased oxygen saturation, decreased heart rate and breathing rate. Conclusions: The strategy for choosing an antidepressant to provide multidisciplinary care for somatoform disorders in women with exacerbation of severe COPD (group D) should take into account the efficacy and favorable safety profile and personalization of the drug. In exacerbation of severe COPD, the degree of somatoform disorders in patients correlates with the severity of the main criteria: FVC1, the distance walked during the 6-minute step test, oxygen saturation after the 6-minute step test, end-expiratory pressure in the oral cavity.
  • Ескіз недоступний
    Документ
    Current strategy for treatment of comorbid states: complicated community-acquired pneumonia with arterial hypertension
    (Wydawnictwo Aluna, Polska, 2020) Burya, L. V.; Vakhnenko, A. V.; Moiseieva, N. V.; Kapustianska, A. A.; Zviagolska, I. M.; Буря, Лілія Володимирівна; Вахненко, Андрій Вікторович; Моісєєва, Наталія Віталіївна; Капустянська, Анна Анатоліївна; Звягольська, Ірина Миколаївна; Буря, Лилия Владимировна; Вахненко, Андрей Викторович; Моисеева, Наталья Витальевна; Капустянская, Анна Анатольевна; Звягольская, Ирина Николаевна
    The aim: To optimize the treatment of CAP patients with hypertension, complicated by exudative pleuritis. Materials and methods: The study included 43 CAP patients, aged 46 to 65 years, with viral lesions along with hypertension. The average age of the patients was 52.5 ± 4.5 years. Veri cation of the CAP diagnosis and its formulation was performed in accordance with the order of the Ministry of Health of Ukraine No. 128 of 19.03.2007 “On the approval of clinical protocols of medical care in “Pulmonology” in all patients, pneumonia was complicated by exudative pleuritis, which was con rmed by X-ray examination. Results: The use of combination drugs, namely, torasemide with prolonged e ect and tivortin aspartate in the treatment of patients with community-acquired pneumonia, complicated by exudative pleuritis, combined with hypertension led to more signi cant positive changes in the values of saturation, blood biochemical parameters, as well as accelerated recovery of patients, which was con rmed by the positive dynamics of X-ray examination. Conclusions: As a result of the treatment, all parameters of the quality of life of the patients were greatly improved, which resulted in a signi cant reduction in functional limitations and high social activity of the patients, which signi cantly reduced the cost of treatment.